{"total":54,"page":1,"pageSize":25,"pages":3,"millis":0,"query":{"q":"","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","kind":"","level":"","type":"","quarter":"","grade":"","collection":"","from":"2020-03-29","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-058","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Indian Health Service","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Indian Health Service (Principal Deputy Director Rear Adm. Michael D. Weahkee)","instrument":"IHS Coronavirus (COVID-19) News page listing the Tribal and Urban Indian Organization Leader letters of Mar. 9, 16, 23 and 27, 2020 (archived Mar. 29, 2020)","title":"Coronavirus (COVID-19) / News: Tribal and Urban Indian Organization Leader Messages on COVID-19","dateIssued":"2020-03-29","startDate":"2020-03-29","endDate":"2020-06-30","quarters":["2020Q2"],"types":["HC","EMER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-058","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-058"},{"id":"AGY-FED-HEALTH-OTHER-028","kind":"context","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment","instrument":"OTP Guidance for Patients Quarantined at Home with the Coronavirus (doorstep delivery protocol) (updated Mar. 30, 2020)","title":"OTP Guidance for Patients Quarantined at Home with the Coronavirus","dateIssued":"2020-03-30","startDate":"2020-03-30","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","QUAR","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-028","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-028"},{"id":"AGY-FED-HEALTH-OTHER-014","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division (with SAMHSA)","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-022 (DEA068), letter permitting DATA-waived practitioners to prescribe buprenorphine to new patients on the basis of a telephone evaluation during the COVID-19 emergency","title":"DEA/SAMHSA Buprenorphine Telemedicine (Final)","dateIssued":"2020-03-31","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-014","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-014"},{"id":"AGY-FED-HEALTH-OTHER-015","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division","instrument":"DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)","title":"How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency","dateIssued":"2020-03-31","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-015","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-015"},{"id":"AGY-FED-HEALTH-OTHER-046","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency (Apr. 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency","dateIssued":"2020-04-01","startDate":"2020-04-01","endDate":"2023-11-07","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-046","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-046"},{"id":"AGY-FED-HEALTH-OTHER-073","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Director, Federal Bureau of Prisons","instrument":"COVID-19 Action Plan: Phase Five (ordered Mar. 31, 2020; effective Apr. 1, 2020): inmates secured in assigned cells/quarters for 14 days; quarantine of new admissions","title":"COVID-19 Action Plan: Phase Five - Additional Agency-wide Actions Effective April 1","dateIssued":"2020-03-31","startDate":"2020-04-01","endDate":"2020-05-18","quarters":["2020Q2"],"types":["QUAR","GATH","CLOSE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-073","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-073"},{"id":"AGY-FED-HEALTH-OTHER-002","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19, 85 Fed. Reg. 19392 (Apr. 7, 2020)","title":"Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19","dateIssued":"2020-04-02","startDate":"2020-04-02","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-002","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-002"},{"id":"AGY-FED-HEALTH-OTHER-082","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Justice, Office of the Attorney General","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William P. Barr, Attorney General","instrument":"Memorandum for Director of Bureau of Prisons, Increasing Use of Home Confinement at Institutions Most Affected by COVID-19 (Apr. 3, 2020)","title":"Increasing Use of Home Confinement at Institutions Most Affected by COVID-19","dateIssued":"2020-04-03","startDate":"2020-04-03","endDate":"2023-05-10","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-082","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-082"},{"id":"AGY-FED-HEALTH-OTHER-076","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Federal Bureau of Prisons","instrument":"Update on COVID-19 and Home Confinement (Apr. 5, 2020)","title":"Update on COVID-19 and Home Confinement: BOP continuing to aggressively screen potential inmates","dateIssued":"2020-04-05","startDate":"2020-04-05","endDate":"2020-06-30","quarters":["2020Q2"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-076","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-076"},{"id":"AGY-FED-HEALTH-OTHER-016","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registration","title":"Off-site OTP delivery method (Final)","dateIssued":"2020-04-07","startDate":"2020-04-07","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-016","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-016"},{"id":"AGY-FED-HEALTH-OTHER-003","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office for Civil Rights","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Roger T. Severino, Director, Office for Civil Rights, HHS","instrument":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020)","title":"Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency","dateIssued":"2020-04-09","startDate":"2020-04-09","endDate":"2023-05-11","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-003","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-003"},{"id":"AGY-FED-HEALTH-OTHER-053","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Face Shields (umbrella) (issued Apr. 9, 2020; amended Apr. 13, 2020)","title":"Letter of Authorization, Face Shields (Apr. 13, 2020)","dateIssued":"2020-04-13","startDate":"2020-04-09","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-053","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-053"},{"id":"AGY-FED-HEALTH-OTHER-017","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programs","title":"DEA Dist/MNF narcotics shipments to OTP signed delivery exception (final)","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-017","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-017"},{"id":"AGY-FED-HEALTH-OTHER-018","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-028 (DEA084), letter permitting DEA-registered hospitals and clinics to handle controlled substances at satellite locations under the existing registration during the COVID-19 emergency","title":"Hospital/Clinic Registration Exception (final)","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-018","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-018"},{"id":"AGY-FED-HEALTH-OTHER-118","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Secretary of Health and Human Services (terms administered by HRSA)","instrument":"Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General Distribution","title":"Acceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-118","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-118"},{"id":"AGY-FED-HEALTH-OTHER-019","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergency","title":"DEA 5 percent practitioner exception (final)","dateIssued":"2020-04-13","startDate":"2020-04-13","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-019","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-019"},{"id":"AGY-FED-HEALTH-OTHER-020","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","instrument":"DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programs","title":"Off site OTP delivery buprenorphine","dateIssued":"2020-04-21","startDate":"2020-04-21","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-020","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-020"},{"id":"AGY-FED-HEALTH-OTHER-025","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies","instrument":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","title":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","dateIssued":"2020-04-21","startDate":"2020-04-21","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-025","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-025"},{"id":"AGY-FED-HEALTH-OTHER-033","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability, 85 Fed. Reg. 27987 (May 12, 2020)","title":"Guidance Documents Related to Coronavirus Disease 2019 (COVID-19); Availability","dateIssued":"2020-05-12","startDate":"2020-05-12","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-033","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-033"},{"id":"AGY-FED-HEALTH-OTHER-077","kind":"order","level":"federal","jurisdiction":"United States (federal); Federal Bureau of Prisons","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Director, Federal Bureau of Prisons","instrument":"COVID-19 Action Plan: Phase Seven (ordered May 18, 2020): all Phase Six measures extended through June 30, 2020","title":"COVID-19 Action Plan: Phase Seven - Agency-wide measures extended","dateIssued":"2020-05-20","startDate":"2020-05-18","endDate":"2020-06-30","quarters":["2020Q2"],"types":["GATH","QUAR","CLOSE","TRAV"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-077","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-077"},{"id":"AGY-FED-HEALTH-OTHER-054","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Denise M. Hinton, Chief Scientist, FDA","instrument":"Emergency Use Authorization: Gowns and Other Apparel (umbrella) (May 22, 2020)","title":"Letter of Authorization, Gowns and Other Apparel","dateIssued":"2020-05-22","startDate":"2020-05-22","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-054","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-054"},{"id":"AGY-FED-HEALTH-OTHER-063","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs","instrument":"Interim Final Rule, Informed Consent and Advance Directives, 85 Fed. Reg. 31698 (May 27, 2020)","title":"Informed Consent and Advance Directives","dateIssued":"2020-05-27","startDate":"2020-05-27","endDate":"2022-02-04","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-063","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-063"},{"id":"AGY-FED-HEALTH-OTHER-035","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019, 85 Fed. Reg. 33686 (June 2, 2020)","title":"Process for Publishing Emergency Use Authorizations for Medical Devices During Coronavirus Disease 2019","dateIssued":"2020-06-02","startDate":"2020-06-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-035","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-035"},{"id":"AGY-FED-HEALTH-OTHER-034","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Notice, Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability, 85 Fed. Reg. 34638 (June 5, 2020)","title":"Authorization of Emergency Use of Certain Medical Devices During COVID-19; Availability","dateIssued":"2020-06-05","startDate":"2020-06-05","endDate":"2021-06-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-034","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-034"},{"id":"AGY-FED-HEALTH-OTHER-062","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs","instrument":"Interim Final Rule, Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency, 85 Fed. Reg. 34523 (June 5, 2020)","title":"Home Visits in Program of Comprehensive Assistance for Family Caregivers During COVID-19 National Emergency","dateIssued":"2020-06-05","startDate":"2020-06-05","endDate":"","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-062","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-062"}],"facets":{"kind":[{"value":"order","label":"Order","count":46},{"value":"context","label":"Context (guidance or announcement)","count":8}],"level":[{"value":"federal","label":"Federal","count":54}],"state":[],"type":[{"value":"OTHER","label":"Other","count":35},{"value":"HC","label":"Health care orders","count":32},{"value":"SUPPLY","label":"Supply chain","count":9},{"value":"TELE","label":"Telework mandate","count":9},{"value":"SCH","label":"Schools and child care","count":6},{"value":"GATH","label":"Gathering cap","count":5},{"value":"QUAR","label":"Quarantine and isolation","count":4},{"value":"CLOSE","label":"Business closure","count":3},{"value":"EMER","label":"Emergency declaration","count":3},{"value":"EMP","label":"Workplace rules","count":3},{"value":"MASK","label":"Face-covering requirement","count":3},{"value":"VAX","label":"Vaccination or testing","count":3},{"value":"TRAV","label":"Travel and quarantine","count":2},{"value":"CAP","label":"Capacity limit","count":1},{"value":"CRT","label":"Courts and public offices","count":1}],"quarter":[{"value":"2021Q3","label":"2021 Q3","count":39},{"value":"2021Q1","label":"2021 Q1","count":32},{"value":"2021Q2","label":"2021 Q2","count":32},{"value":"2020Q4","label":"2020 Q4","count":31},{"value":"2020Q3","label":"2020 Q3","count":28},{"value":"2020Q2","label":"2020 Q2","count":26}],"grade":[{"value":"primary","label":"Primary source read","count":52},{"value":"secondary","label":"Confirmed from a secondary source","count":2}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":54}]}}